NIH | National Cancer Institute | NCI Wiki  

WIKI MAINTENANCE NOTICE

Please be advised that NCI Wiki will be undergoing maintenance on Thursday, May 23rd between 1200 ET and 1300 ET.
Wiki will remain available, but users may experience screen refreshes or HTTP 502 errors during the maintenance period. If you encounter these errors, wait 1-2 minutes, then refresh your page.

If you have any questions or concerns, please contact the CBIIT Atlassian Management Team.

Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.
Comment: Revised the wiki page title to match the customer-facing page.

Anchor
recordtrialid
recordtrialid
HTML Comment
hiddentrue

Screenshot TBD.

How to Complete the Trial Identifiers Section
In the various fields, specify the appropriate information. The following procedure describes the fields. All fields except the ClinicalTrials.gov Identifier are required.

  1. Click Please Select the Lead Organization.
    A list of organizations that are principal administrative organizations responsible for the study appears.
  2. Select the organization from the list.
  3. If the lead organization is not listed, click Search, and follow the instructions in Searching for Organizations.
  4. Enter the Lead Organization Trial Identifier, the unique identification used to identify, name, or characterize the protocol document, exactly the same as it appears in the protocol document. For Inter-Group trials, type the Lead Group's trial number. For multi-site trials that have no assigned single center, use the protocol ID.
    Example: NSABP-B-40
  5. Click Please Select Submitting Organization.
    A list of affiliated organizations appears.
  6. Select the organization from the list.
  7. If the submitting organization is not listed, click Search, and follow the instructions in Searching for Organizations.
  8. Enter the Submitting Organization Local Trial Identifier exactly the same as it appears in the protocol document.
  9. Optionally, enter the number assigned to the trial by PRS (ClinicalTrials.gov).